XERS - Xeris Biopharma Holdings Inc. (XERS) Q1 2024 Earnings Call Transcript
2024-05-09 12:49:14 ET
Xeris Biopharma Holdings, Inc. (XERS)
Q1 2024 Earnings Conference Call
May 09, 2024, 08:30 ET
Company Participants
Allison Wey - SVP, IR & Corporate Communications
Paul Edick - Chairman & CEO
Steven Pieper - CFO
Conference Call Participants
Oren Livnat - H.C. Wainwright & Co.
Roanna Ruiz - Leerink Partners
Rohan Mathur - Oppenheimer
Kelly Close - Analyst
Presentation
Operator
Hello, everyone, and welcome to the Xeris Biopharma First Quarter 2024 Financial Results Conference Call and Webcast. My name is Seth, and I'll be the operator for your call today.
[Operator Instructions]. I will now hand the floor over to Allison Wey to begin the call. Please go ahead when you're ready.
Allison Wey
Thank you, John. Good morning and welcome to Xeris' first quarter 2024 financial result conference call and webcast. This morning, we issued our press releases, which can be found on our website. We're joined this morning by Paul Edick; Chairman and CEO, and Steve Pieper; our CFO. After our prepared remarks, we will open the lines for questions.
Before we begin, I would like to remind you that this call will contain forward-looking statements concerning the company's future expectations, plans, prospects, and financial performance. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those forward-looking statements.
For more information on such risks, please refer to our earnings press release and risk factors included in our SEC filings in our annual report on Form 10-K that will be filed following this call. Any forward-looking statements in this call represent our views only as of the date of this call and subject to applicable law. We disclaim any obligations to update such statements....
Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript